Global levels of histone modifications predict prognosis in different cancers.
about
Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformationTargeting the epigenome in lung cancer: expanding approaches to epigenetic therapyState of the science: an update on renal cell carcinomaOne-Carbon Metabolism in Prostate Cancer: The Role of Androgen SignalingEpigenetics in non-small cell lung cancer: from basics to therapeuticsEpigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathologyGlobal histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsDysregulated metabolism contributes to oncogenesisHistone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and preventionEpigenetics of lung cancerEpigenetics meets radiation biology as a new approach in cancer treatmentHistone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinomaNew Progress of Epigenetic Biomarkers in Urological CancerThe Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear StructureHistone methylation: a dynamic mark in health, disease and inheritanceThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerEnvironmental chemical exposures and human epigeneticsOver-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancerTip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA.Histone H1 phosphorylation in breast cancerElevated MED28 expression predicts poor outcome in women with breast cancer.Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples.Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastomaLung cancer: a modified epigenome.Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells.PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples.Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.UHRF1 is a genome caretaker that facilitates the DNA damage response to gamma-irradiationEpigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes.Epigenetics and cancer.Epigenetics and chromatin remodeling play a role in lung diseaseAlterations of global histone H4K20 methylation during prostate carcinogenesis.Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.Histone modifications and chromatin organization in prostate cancerQuantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells.Quantitating the specificity and selectivity of Gcn5-mediated acetylation of histone H3.
P2860
Q24319697-A26573F5-7651-4B8E-BC95-353A84B70D20Q24338723-4CF9C6F1-6822-444C-9F58-7C3AB624EC6CQ24609974-B669C57C-F91B-43C9-99BB-8C19C1EC1D89Q24630685-4E84E74B-B340-4B0E-B800-E3A82F8C8969Q26740548-C06D7AE8-9042-47D0-9338-2D098F928339Q26749113-5A97E8F0-E200-41B3-8E3E-832C6417917FQ26752925-FC67FD57-F4E6-45D9-96A2-62D9768CD59AQ26775413-81661196-DF2E-4046-9093-8F72E9667DC8Q26781745-6FB91144-1DBF-46D7-B3D5-9D50AA923EC2Q26784630-01FFE917-2623-4521-A31F-31DF3A7E0663Q26994739-EEF0EB1F-7B97-41F4-A2B6-94A4CE7C00DFQ26996766-92AF3B1D-DAB3-4097-AA4F-E0E0981AE5A5Q27014984-E97EF5CA-9076-4791-81C6-A2B48C2DDC57Q27025984-13F0B39E-69F7-47B6-910A-E35FE2A59CE1Q28073982-D38928BD-DE61-44EE-9AC8-CDDCC7A2353CQ28084785-B1390C6B-056B-42FC-8C58-DEF35A367ED3Q28263573-322C5BE0-065D-4D35-A6E9-BB892B2FD09BQ28387891-52E856DF-B564-40A3-805F-C46A8E77B669Q28397621-CB0A2A9F-5CD6-4919-81D7-0960DB474605Q28482156-30BF1B45-B5ED-4309-BC91-71447AC0E052Q30413802-9BCBFA0B-AD19-4C99-A8A4-41A91E70DC9CQ33577337-F05E1F91-04E3-4230-A49C-0CA1BAEA6851Q33618514-4320F2C1-AA0F-43F9-881E-3153D7DF922BQ33711106-383656F2-957A-475A-8592-593698CC4A23Q33755701-B7E70276-C60B-4858-B7B7-95863111B3EBQ33771160-F0E1549C-0A1E-4819-9326-C62D6A152FFFQ33781123-67185226-E61B-490F-8DBC-FF272ACDCE96Q33813964-442651C4-97E7-402F-8EAE-6F4701EE5D7CQ33892492-3D9B7B4D-244F-4EED-8498-E3E4EFFDB486Q33937454-64C21BEE-57DC-4D22-8D5F-951DDC35080AQ34033964-EA890A2D-7568-4DCF-BB8C-2FA5495CDE9AQ34036281-5B288E97-513F-4387-A6E3-D22F82500B16Q34084746-85103467-B069-4B16-ACD9-E4FF503DAFC8Q34085532-9D53525E-4DDE-4B20-AEE4-EBB38E39E1D6Q34126445-E6B9E67D-A6E7-44F9-B40F-54EEA322A312Q34194181-D743CA26-C6F1-4930-BEE5-02C632E1DF4FQ34500688-959B0B98-EBE5-467A-AEE5-214B16F63798Q34559303-ABE17B61-B0AE-467B-853D-0DB7661D3251Q34581453-9D6CF4C5-6C52-46D4-9BD5-8412FCF4CF26Q34598080-4857C1B1-BBBB-42EA-8956-8D8F5CE40407
P2860
Global levels of histone modifications predict prognosis in different cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global levels of histone modifications predict prognosis in different cancers.
@en
Global levels of histone modifications predict prognosis in different cancers.
@nl
type
label
Global levels of histone modifications predict prognosis in different cancers.
@en
Global levels of histone modifications predict prognosis in different cancers.
@nl
prefLabel
Global levels of histone modifications predict prognosis in different cancers.
@en
Global levels of histone modifications predict prognosis in different cancers.
@nl
P2093
P2860
P1476
Global levels of histone modifications predict prognosis in different cancers.
@en
P2093
David B Seligson
David Chia
Lee Goodglick
Matthew A McBrian
Sheila Tze
Steve Horvath
P2860
P304
P356
10.2353/AJPATH.2009.080874
P407
P577
2009-04-06T00:00:00Z